Safety studies for clinical trials of a botanical drug for sickle cell disease
Ended Project Grant Awarded Last action
- Award ID
- R44HL119086
- Recipient
-
Invenux, LLC UEI TE98A4TS48J1
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,499,750
Award facts
- Assistance listing
- 93.837 Cardiovascular Diseases Research
- Completion date
- Originally
- Place of performance
- Colorado, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $692,340 | |
| Original award | $807,410 |
Quick answers
Who received award R44HL119086?
R44HL119086 was awarded to Invenux, LLC by National Heart Lung and Blood Institute (National Institutes of Health) on July 1, 2013.
How much is award R44HL119086 worth?
$1,499,750 has been obligated on R44HL119086.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award